According to Straits Research, the global AI in pathology market size was valued at $166.41 million in 2025 and is expected to reach $1,140.55 million by 2034, registering a CAGR of 23.8% during the forecast period (2026–2034) The AI in pathology market is segmented based on offering, technology, application, end use, and region. Some of the insights provided in the report are highlighted below: The hardware segment is expected to be the fastest growing with a CAGR of 25.16% during the forecast period. North America is expected to lead the market during the forecast period, owing to the growing prevalence of cancer and the availability of a strong digital framework. Healthcare providers, such as laboratory officials, are adopting AI-supported pathology solutions for rising volumes. China is expected to lead the Asia Pacific market by integrating AI tools to address the shortage of pathologists. Straits Research adopts a rigorous 360° research approach that integrates both primary and secondary research methodologies. The report data is triangulated with a mix of market indicators, macroeconomic outlook, industry sources, and strategic briefings. The report is designed to enable decision-makers, such as CXOs, policymakers, investors, startups, and other related stakeholders, to understand the current and future scenario of the market. Market Segments By Offering Hardware Imaging Scanners AI-enabled Microscopes Digital Pathology Systems Software Workflow Management Data Management Image Analysis Predictive Analytics Tools Services By Technology Machine Learning Computer Vision-based Image Analysis Natural Language Processing By Application Drug Discovery Disease Diagnosis & Prognosis Training & Education By End Use Pharmaceutical & Biotechnology Companies Hospital & Reference Laboratories Academic & Research Institutes By Region North America Europe APAC Middle East and Africa LATAM